Who Paid My Doc
Ortholoc 3Di
Device Trauma & Extremities
PDI 00840420112996
General payments
$7,110,068
Research payments
$261,082
Through program year 2025, $7,110,068 in general payments and $261,082 in research payments were reported against Ortholoc 3Di (Trauma & Extremities).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,450,464 | 2,155 |
| 2025 | Research | $8,825 | 1 |
| 2024 | General | $1,849,826 | 4,588 |
| 2024 | Research | $16,796 | 2 |
| 2023 | General | $1,049,042 | 1,640 |
| 2023 | Research | $18,212 | 3 |
| 2022 | General | $940,906 | 1,844 |
| 2022 | Research | $21,120 | 3 |
| 2021 | General | $819,830 | 1,042 |
| 2021 | Research | $196,129 | 8 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 41 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
11,269 general · 17 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.